Clinicopathologic features of AR positive and AR negative TNBC.

<p>Clinicopathologic features of AR positive and AR negative TNBC.</p

High risk TNBC.

<p>Morphology as seen on H&E stain (A) and characterized by low AR immunopositivity (B), high Ki-67 (C), and positive EGFR (D).</p

Apocrine differentiation in AR positive TNBC.

<p>Hematoxylin and Eosin (H&E) stain, 20x.</p

Disease free survival of TNBC stratified by AR and EGFR.

<p>Cases were stratified into three risk groups: 1. Low risk: AR+ EGFR-; 2. Intermediate risk: AR+ EGFR+ or AR- EGFR-; 3. High Risk: AR- EGFR+.</p

Inverse correlation of AR expression and proliferation rate as measured by Ki-67 immunostain (Correlation coefficient -0.367; p = 1.009e-5).

<p>Inverse correlation of AR expression and proliferation rate as measured by Ki-67 immunostain (Correlation coefficient -0.367; p = 1.009e-5).</p

AR immunoexpression in TNBC.

<p>>50% of neoplastic cells are positive. 20x.</p

Prognostic groups of TNBC as stratified by AR and EGFR.

<p>Prognostic groups of TNBC as stratified by AR and EGFR.</p

Low risk TNBC.

<p>Morphology as seen on H&E stain (A) and characterized by strong AR immunopositivity (B), low Ki-67 (C), and negative EGFR (D).</p

Disease free survival of patients with AR positive and AR negative TNBC.

<p>Group A, left column (study set, n = 35), and Group B, right column (validation set, n = 100) at different thresholds of 1%, 10%, 25% and 30% from top to bottom.</p

Prognostic value of clinicopathological variables in predicting disease free survival using univariate and multivariate Cox model.

<p>Prognostic value of clinicopathological variables in predicting disease free survival using univariate and multivariate Cox model.</p